0000749660-20-000046.txt : 20201207 0000749660-20-000046.hdr.sgml : 20201207 20201207164158 ACCESSION NUMBER: 0000749660-20-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stevens Stacey M CENTRAL INDEX KEY: 0001362512 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09341 FILM NUMBER: 201373179 MAIL ADDRESS: STREET 1: C/O ICAD, INC. STREET 2: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICAD INC CENTRAL INDEX KEY: 0000749660 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 020377419 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 BUSINESS PHONE: 603-882-5200 MAIL ADDRESS: STREET 1: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 FORMER COMPANY: FORMER CONFORMED NAME: HOWTEK INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-12-03 0 0000749660 ICAD INC icad 0001362512 Stevens Stacey M C/O ICAD, INC. 98 SPIT BROOK ROAD, SUITE 100 NASHUA NH 03062 0 1 0 0 President Common Stock 2020-12-03 4 M 0 1100 6.68 A 172888 D Common Stock 2020-12-03 4 S 0 1100 11.0736 D 171788 D Common Stock 2020-12-04 4 M 0 18665 6.68 A 190453 D Common Stock 2020-12-04 4 S 0 18665 11.2768 D 171788 D Employee Stock Option (right to buy) 6.68 2020-12-03 4 M 0 1100 0 D 2015-06-19 2024-06-19 Common Stock 1100 0 D Employee Stock Option (right to buy) 6.68 2020-12-04 4 M 0 5567 0 D 2015-06-19 2024-06-19 Common Stock 5567 0 D Employee Stock Option (right to buy) 6.68 2020-12-04 4 M 0 6667 0 D 2016-06-19 2024-06-19 Common Stock 6667 0 D Employee Stock Option (right to buy) 6.68 2020-12-04 4 M 0 6431 0 D 2017-06-19 2024-06-19 Common Stock 6431 0 D These share were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on December 3, 2020 and December 4, 2020. /s/ Annette Heroux, Attorney-in-Fact 2020-12-07